WWA-31347-52966 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-29
Dose 1 — Moderna
2021-02-26
Dose 2 — Moderna
2021-02-27
Registered in v-safe
2021-02-27
Survey response — days 1–6 daily, dose 2
MedDRA: Hypersensitivity — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Hypersensitivity

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-27
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-02-28
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-29	Moderna
2	2021-02-26	Moderna

Call center

Reported	Outcome	VAERS-related outcome
2021-02-27	priority 2/3

Free text

Release 4 — days 1–6 daily, dose 2

2021-02-27

Systemic reaction (other): Hypersensitivity

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Hypersensitivity	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release